Market research

For retail sale medicaments with insulin market in Denmark

Release date: Mar 29, 2026

Submission: 15 minutes after payment

Research period: 2017-2025

Report language:

Report language:

Submission method: to your account

File format: docx, xlsx

Single Report

$500

Instant access to detailed data on one specific market
Ideal for one-off tasks: niche assessments, presentations, investment decisions
Available in Excel and Word in 15 minutes after purchase
Cheaper than subscription, but each market requires a separate purchase

Best if you know exactly what you need

Buy a single report

Platform Subscription

from$600

Complete and unlimited data access across products and regions
Includes continuous data updates during subscription period
Download reports instantly in Word, and Excel formats
More cost-effective for multiple markets or regular analysis

Ideal for regular data users

View pricing plans

Earlier Report Observations

The market for packed retail insulin medicaments in Denmark contracted substantially between 2018 and 2024, with its value falling from 8 100 million dollars to 2 228 million dollars. A steep decline of over 50% occurred in 2021, reducing the market to 3 068 million dollars, followed by a further drop to 2 133 million dollars in 2022. A temporary rebound in 2023 saw the market grow by 18% to 2 515 million dollars, before resuming its downward trend.

The market value decreased by 11% to 2 228 million dollars in 2024. This movement coincided with the introduction of a new national pricing scheme that fixed uniform medicine prices across all pharmacies to lower costs, directly reducing the market's monetary value. Concurrently, new clinical guidelines for gestational diabetes more than doubled the share of pregnant women receiving insulin treatment, while prescribing restrictions for GLP-1 drugs like Ozempic likely shifted some demand toward insulin therapies, affecting the overall demand landscape.

Table of content

1. Disclaimer
2. Terms of use of the report
3. Product codes in the statistical classifications used in the report
4. Key Market Indicators and Trends
1. 4.1. Key Market Indicators
  1. 4.1.1. In value
    1. 4.1.1.1. Production, 2018-2024
    2. 4.1.1.2. Imports, 2018-2024
    3. 4.1.1.3. Exports, 2018-2024
    4. 4.1.1.4. Market size, 2018-2024
2. 4.2. Market Trends and Factors
5. Production
1. 5.1. Production in Denmark
  1. 5.1.1. In value, 2018-2024, M $ US
2. 5.2. Production in the EU, 2018-2024
  1. 5.2.1. In value, 2018-2024, M $ US
6. Trade balance
1. 6.1. Trade balance (Direct Data)
  1. 6.1.1. In kind, kg
  2. 6.1.2. In value, $ US
2. 6.2. Trade balance (Mirror Data)
  1. 6.2.1. In kind, kg
  2. 6.2.2. In value, $ US
7. Top buying and selling countries, 2018-2024
1. 7.1. Direct Data
  1. 7.1.1. Import in Value by Countries-buyers
  2. 7.1.2. Export in Value by Countries-suppliers
2. 7.2. Mirror Data
  1. 7.2.1. Import in Value by Countries-buyers
  2. 7.2.2. Export in Value by Countries-suppliers

Production for retail sale medicaments with insulin in Denmark

In value, 2017-2020, M $ US

Denmark's production volume of insulin-based retail sale medicaments declined for the second consecutive year. In 2020, output was valued at 6 770 million US dollars, marking a 6.5% decrease compared to 2019. Over the 2017-2020 period, production fell by 13.9%, with a compound annual growth rate (CAGR) of -4.9%. The highest production value was recorded in 2018 at 8 100 million US dollars, which represented a 3.0% increase from the previous year. The most significant decline occurred in 2019, with a drop of 10.6%.

Annual dynamics of production in Denmark in value, 2017-2020, M $ US

Parameter		2018	2019	2020	CAGR
1	Change from last year	3.0%	(10.6%)	(6.5%)	(4.9%)

Source: SHEV.io

Exports for retail sale medicaments with insulin from Denmark

Market analysis indicates that Denmark did not export any insulin-based retail sale medicaments from 2017 to 2020.

Imports for retail sale medicaments with insulin to Denmark

Market reports highlight that Denmark did not import any insulin-based retail sale medicaments from 2017 to 2020.

Related Reports

For retail sale medicaments with insulin market in Hungary

2026-03-29

$420

Buy

For retail sale medicaments with insulin or hormones or antibiotics market in Denmark

2026-03-29

$500

Buy

Aromatic ethers and derivatives market in Denmark

2026-03-29

$500

Buy

Printing, writing and drawing inks market in Denmark

2026-03-29

$500

Buy

Brake fluids and antifreezes market in Denmark

2026-03-30

$500

Buy

Why Choose Us?

Only Verified Data

We provide data exclusively verified by trusted sources and our proprietary validation algorithms.

Сompetitors offer unverified rough estimates, which can differ greatly from reality and therefore cannot be reliably used for decision-making

No Hidden Costs or Separate Fees

All critical data is included in our reports at no extra cost (e.g. top importers and exporters)

Competitors charge separately for essential sections, making their final reports significantly more expensive compared to ours

Smarter Subscription Pricing

Our subscription plans are among the best on the market, offering excellent value and flexibility

Competitors typically set significantly higher prices while offering fewer features and more limited data access

Contact Our Team

Submit your inquiry using the form below — our team will get back to you within 24 hours.